Literature DB >> 15805881

Role of interleukins and transforming growth factor-beta in chronic rhinosinusitis and nasal polyposis.

Dewayne T Bradley1, Stilianos E Kountakis.   

Abstract

OBJECTIVES: To determine the role of interleukin (IL)-4, IL-4 receptor (R), IL-6, IL-8, IL-11, and transforming growth factor (TGF)-beta in chronic rhinosinusitis (CRS) and chronic rhinosinusitis with nasal polyposis (CRS/NP).
METHODS: Sinus tissue from patients undergoing endoscopic sinus surgery for CRS and CRS/NP was collected. Sinus tissue was then analyzed using reverse-transcription polymerase chain reaction (RT-PCR) to detect transcription of IL-4R, IL-6, IL-8, and IL-11. Sinus tissue samples were also cultured in vitro, treated with IL-4 for 24 hours, and real-time PCR was used to quantify the transcription of TGF-beta.
RESULTS: Twenty patients were evaluated, 9 with CRS/NP and 11 with CRS alone. The mean age was 43 (20-74) years, with 13 females and 7 males. IL-4R, IL-6, IL-8, and IL-11 were identified by RT-PCR in all 20 patients. The transcription of TGF-beta was found to be 3.2 times greater in patients with CRS/NP than in patients with CRS alone (P = .047).
CONCLUSION: IL-6, IL-8, and IL-11 are nonspecific markers of sinus inflammation being transcribed in patients with CRS and patients with CRS/NP. However, patients with CRS/NP demonstrate increased transcription of TGF-beta in response to IL-4 treatment, suggesting an IL-4 mediated mechanism for stromal proliferation in the formation of nasal polyposis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15805881     DOI: 10.1097/01.mlg.0000161334.67977.5D

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  Pro-inflammatory effects of ochratoxin A on nasal epithelial cells.

Authors:  Birgit Cremer; Alexandra Soja; Jan-Alex Sauer; Michael Damm
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-02       Impact factor: 2.503

2.  Immunological profiling in chronic rhinosinusitis with nasal polyps reveals distinct VEGF and GM-CSF signatures during symptomatic exacerbations.

Authors:  R D Divekar; S Samant; M A Rank; J Hagan; D Lal; E K O'Brien; H Kita
Journal:  Clin Exp Allergy       Date:  2015-04       Impact factor: 5.018

3.  Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps.

Authors:  Anju T Peters; Atsushi Kato; Ning Zhang; David B Conley; Lydia Suh; Brian Tancowny; Derek Carter; Tara Carr; Michael Radtke; Kathryn E Hulse; Sudarshan Seshadri; Rakesh Chandra; Leslie C Grammer; Kathleen E Harris; Robert Kern; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

4.  [Immunocytochemical detection of caspase 3 in various diseases of human nasal mucosa].

Authors:  R Hirt; F Paulsen; K Neumann; S Knipping
Journal:  HNO       Date:  2009-05       Impact factor: 1.284

Review 5.  Pathogenesis of nasal polyps: an update.

Authors:  Rafal Pawliczak; Anna Lewandowska-Polak; Marek L Kowalski
Journal:  Curr Allergy Asthma Rep       Date:  2005-11       Impact factor: 4.919

6.  Expression and Regulation of Transcription Factor FoxA2 in Chronic Rhinosinusitis With and Without Nasal Polyps.

Authors:  Qing Luo; Jia Zhang; Hongtian Wang; Fenghong Chen; Xi Luo; Beiping Miao; Xingmei Wu; Renqiang Ma; Xiangqian Luo; Geng Xu; Jianbo Shi; Huabin Li
Journal:  Allergy Asthma Immunol Res       Date:  2015-05-22       Impact factor: 5.764

7.  Role of caffeic Acid on collagen production in nasal polyp-derived fibroblasts.

Authors:  Seung Won Chung; Il-Ho Park; Sung-Moon Hong; Jung-Sun Cho; Jun-Hyeok Moon; Tae Hoon Kim; Heung-Man Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2014-11-14       Impact factor: 3.372

8.  Characterization of Cytokines and Proliferation Marker Ki67 in Chronic Rhinosinusitis with Nasal Polyps: A Pilot Study.

Authors:  Rudolfs Janis Viksne; Gunta Sumeraga; Mara Pilmane
Journal:  Medicina (Kaunas)       Date:  2021-06-11       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.